Please login to the form below

Not currently logged in
Email:
Password:

New accounts: July

The following tables list new pharmaceutical account wins notified to us by the winning agencies for the period April to June 2005 inclusive.

The following tables list new pharmaceutical account wins notified to us by the winning agencies for the period April to June 2005 inclusive. Please note that inclusion in this table does not necessarily indicate exclusivity and other agencies may also be involved with some of the products listed in other ways, or in domestic, overseas or international markets. To submit an entry for New Accounts, email nhobson@pmlive.com

  

Alchemy

Corporate

Corporate

Seven Stones

Boehringer Ingelheim

N/A

N/A

Dark Horse Agency

Chiron Biopharma Europe

N/A

N/A

Woolley Pau

Ferring

NPD

Urology

FCB Healthcare

Genzyme

Thyrogen

Oncology

Big Blue

Gilead Sciences

Emtriva

HIV

FCB HealthCare

Gilead Sciences

Truvada

HIV

FCB HealthCare

Gilead Sciences

Viread

HIV

FCB HealthCare

Gilead (International)

Corporate

HIV

FCB HealthCare

GlaxoSmithKline

New product

Neurology

Euro RSCG Life MSC

Janssen-Cilag

Lyrinel XL

Urinary incontinence

PBC Communications

Novartis

Zelnorm

IBS

The Medical Multimedia Company

Novo Nordisk

Diabetes insulin portfolio

Diabetes

Woolley Pau

Orion Pharma

Tridestra

HRT

Langland

Orion Pharma

Indivina

HRT

Langland

Pfizer

New product

Ophthalmology

The Medical Multimedia Company

Roche Diagnostics

Cobas

Hospital in-vitro diagnostics

PBC Communications

Roche (International)

NPD

Haematology

FCB HealthCare

Trinity-Chiesi Pharmaceuticals

New products

Respiratory portfolio

Swordfish Advertising

2nd September 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Makara Health

Independent healthcare communications agency with a passion to develop inspirational ideas that create sustained and positive change. Whether it is...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics